Skip to main navigation

Investor Relations

Investor Overview
Stock Information
- Stock Quote & Chart
News & Events
- News Releases
- Events
SEC Filings
Corporate Governance
Investor Resources

News Releases

News Releases

19 May '21

Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations

17 May '21

Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial

07 May '21

Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

28 Apr '21

Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical Oncology

10 Apr '21

Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

25 Mar '21

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

10 Mar '21

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

02 Mar '21

Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021

23 Feb '21

Black Diamond Therapeutics to Present at Upcoming Investor Conferences

11 Feb '21

Black Diamond Therapeutics to Present at the BMO Biopharma Spotlight Series

Pagination

First page
Previous page
Current page 1
Page 2
Page 3
Page 4
Page 5
Next page
Last page

Displaying 1 - 10 of 42

Investor Tools

Print Page
E-mail Alerts
RSS Feeds

Request E-mail Alerts

Footer Links

ABOUT US

TECHNOLOGY

PIPELINE

NEWS

CAREERS

CONTACT

© 2021 Black Diamond Therapeutics, Inc. All rights reserved.

Facebook
Twitter
LinkedIn
Google+